Breast Cancer & Cosmetic Surgery | D B Ghosh

D B Ghosh Onco Plastic Breast Surgeon
Menu
Book a Consultation

Research &Publications

✅Malhotra A, Tincey S, Naidu V, Papagiorcopulo C, Ghosh D, Tan PH, Wickham F, Wagner T. Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT in Patients with Breast Cancer-A Proof-of-Concept Study. J Pers Med. 2020 Sep 25;10(4):148. doi: 10.3390/jpm10040148. PMID: 32992995; PMCID: PMC7712852.

✅ Kostoglou A, Vlastos D, Bakalis A, Ghosh D. Breast cancer-associated opsoclonus-myoclonus syndrome: a case report. World J Surg Oncol. 2021 Nov 16;19(1):328. doi: 10.1186/s12957-021-02436-7. PMID: 34781971; PMCID: PMC8594106.

✅ Taj S, Khanfar H, Kostoglou A, Ghosh D. Stage migration of breast cancer patients during Covid-19 pandemic. Eur J Surg Oncol. 2022;48(2):e86. doi:10.1016/j.ejso.2021.12.112

✅ Khanfar H, Kostoglou A, Taj S, Ghosh D. Impact of Covid-19 pandemic on the management of breast cancer patients. Eur J Surg Oncol. 2022 Feb;48(2):e72. doi:10.1016/j.ejso.2021.12.072. Epub 2022 Feb 24. PMCID: PMC8869464.

✅ Jeon FHK, Varghese J, Griffin M, Butler PE, Ghosh D. Systematic review of methodologies used to assess mastectomy flap viability. BJS Open. 2018 May 28;2(4):175-184. doi: 10.1002/bjs5.61. PMID: 30079386; PMCID: PMC6069344.

✅ Banerjee, S. M., N. R. Williams, T. I. Davidson, S. El Sheikh, M. Tran-Dang, S. Davison, D. Ghosh, and M. R. S. Keshtgar. “The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.” European Journal of Surgical Oncology (EJSO) 42, no. 5 (2016): 641-649.

✅ Banerjee, Shramana, Timothy Davidson, Norman Williams, Soha El-Sheikh, My-Annh Tran-Dang, Debashish Ghosh, Stephen Davison, and Mohammed Keshtgar. “P075. A predicitive model for axillary non-sentinel node involvement by one-step nucleic acid amplification (OSNA) and tumour-related factors in the treatment of breast cancer.” European Journal of Surgical Oncology 41, no. 6 (2015): S48.

✅ Sentinella® : A new portable intra-operative gamma camera for Sentinel Node localisation. European Journal of Surgical Oncology (EJSO), Volume 36, Issue 11, November 2010, Page 1111. Debashis Ghosh, A. O’Brien, D. Beck, C. Wickham, T. Davidson, M. Keshtgar.

✅ Intra-operative Sentinella® scans increases the yield of sentinel node biopsy in breast cancer. D. Ghosh¹, V. Staflya¹, A. O’Brien¹, D. Beck¹, C. Wickham², D. McCool², J. Page², T. Davidson¹, M. Keshtgar¹. European Journal of Surgical Oncology (EJSO), Volume 36, Issue 9, September 2010, Pages 795-932.

✅ Intra-operative detection of sentinel lymph node metastases in breast cancer using real time quantitative polymerase chain reaction (RT-PCR). S. Somasundaram¹, D. Ghosh¹, R. McCarthy², S. Davison², N. Byron², T. Davidson¹, N. McDermott², M. Keshtgar¹. European Journal of Surgical Oncology (EJSO), Volume 36, Issue 9, September 2010, Pages 795-932.

✅ K Marimuthu, C Vijayasekar, D Ghosh, G Mathew. “Prevention of parastomal hernia using preperitoneal mesh: a prospective observational study.” Colorectal Disease 8.8 (October 2006): 672–675.

✅ Ghosh D, Morris A, Williams N. “COX-2 inhibitors suppress VEGF expression in colorectal cancer.” Colorectal Disease, 7.1 (June 2005): 45–143.

✅ D Ghosh, G Mathhew, A Reynolds S Lele. The role of CERB-B2 in colorectal cancer. Colorectal Disease 6.3 (May 2004).

✅ K Marimuthu, D Ghosh, G Matthew. Prophylactic mesh in permanent stomas. Colorectal Disease 4.2 (Sept 2004).

✅ Ghosh D, Newbold M, Morris A, Williams N. Tumour progression in colorectal cancer is associated with upregulation of VEGF and increased angiogenesis. Colorectal Disease 4.1 (Jun 2002).

✅ Ghosh D, Newbold M, Morris A, Williams N. COX-2 promotes neovascularisation by increased VEGF production. European Journal of Surgical Oncology 23.3 (April 2002).

✅ Ghosh D, Newbold M, Morris A, Williams N. COX-2 expression correlates with angiogenesis and increasing tumour stage in colorectal cancer. Hepato-Gastroenterology 1.48 (Nov 2001).

✅ Ghosh D, Newbold M, Morris A, Williams N. Stromal expression of Cox-2 is associated with increased angiogenesis in colorectal cancer. Colorectal Disease 3.2 (Sept 2001).

✅ Ghosh D, Newbold M, Morris A, Williams N. Stromal expression of COX-2 increases with advancing stage of colorectal cancer. Colorectal Disease 3.1 (Jun 2001).

✅ Ghosh D, Newbold M, Morris A, Williams N. Cyclooxygenase-2 expression increases microvessel density in colorectal cancer. Colorectal Disease 3.1 (Jun 2001).

✅ D Ghosh, M Newbold, A Morris, N Williams. COX-2 expression increases with increasing Dukes staging in colorectal cancer. Colorectal Disease 3.1 (Jun 2001).

✅ Ghosh D, Newbold M, Morris A, Williams N. COX-2 may act by inducing angiogenesis in colorectal cancer. British Journal of Surgery, 88.11 (May 2001): 70.

✅ Ghosh D, Miller C, Fraser I. Post vasectomy seminal analysis. How many and how long? British Journal of Surgery, 88.11 (May 2001): 70.

Peer-Reviewed Journal Papers (PubMed-indexed)

Full papers indexed in PubMed/MEDLINE. Author name appears as “Ghosh D” — the standard PubMed form of D. B. Ghosh.

  1. Ghosh D, Michalopoulos NV, Davidson T, Wickham F, Williams NR, Keshtgar MR. “Sentinel node detection in early breast cancer with intraoperative portable gamma camera: UK experience.” The Breast 2017;32:53–59. First UK experience — Sentinella® portable gamma cameraPubMed PMID 28033510DOI 10.1016/j.breast.2016.12.013
  2. Banerjee SM, Williams NR, Davidson TI, El Sheikh S, Tran-Dang M, Davison S, Ghosh D, Keshtgar MR. “The use of one-step nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.” European Journal of Surgical Oncology 2016;42(5):641–649.PubMed PMID 26979647DOI 10.1016/j.ejso.2016.02.245
  3. Jeon FHK, Varghese J, Griffin M, Butler PE, Ghosh D, Mosahebi A. “Systematic review of methodologies used to assess mastectomy flap viability.” BJS Open 2018;2(4):175–184.PubMed PMID 30079386DOI 10.1002/bjs5.61
  4. Malhotra A, Tincey S, Naidu V, Papagiorcopulo C, Ghosh D, Tan PH, Wickham F, Wagner T. “Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT in Patients with Breast Cancer — A Proof-of-Concept Study.” Journal of Personalized Medicine 2020;10(4):148.PubMed PMID 32992995DOI 10.3390/jpm10040148Free full text PMC7712852
  5. Kostoglou A, Vlastos D, Bakalis A, Ghosh D. “Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.” World Journal of Surgical Oncology 2021;19(1):328.PubMed PMID 34781971DOI 10.1186/s12957-021-02436-7
  6. Marimuthu K, Vijayasekar C, Ghosh D, Mathew G. “Prevention of parastomal hernia using preperitoneal mesh: a prospective observational study.” Colorectal Disease 2006;8(8):672–675. From his colorectal surgery periodPubMed PMID 16970577DOI 10.1111/j.1463-1318.2006.00996.x

Published Conference Abstracts (with DOI / publisher records)

Abstracts published in journal supplements — European Journal of Surgical Oncology (EJSO), European Journal of Cancer Supplements and the American Journal of Gastroenterology.

  1. Takrouni A, Khanfar H, Mosahebi A, Khan A, Ghosh D. “LYMPHA for Lymphedema Prevention after axillary clearance in Breast Cancer: A Retrospective Case Series.” Eur J Surg Oncol 2025;51(12). LYMPHA — lymphatic microsurgical preventive healingDOI 10.1016/j.ejso.2025.110774
  2. Khanfar H, Rehman B, Hmedat A, Sheri A, Ghosh D. “Comparison between Prosigna genomic test vs NHS Predict tool in early breast cancer.” Eur J Surg Oncol 2024.DOI 10.1016/j.ejso.2023.107487
  3. Khanfar H, Allen N, Torres N, Chaudhary K, Ghosh D. “Diagnostic and surgical challenges in treating squamous cell carcinoma of breast implant capsule.” Eur J Surg Oncol 2023.DOI 10.1016/j.ejso.2022.11.635
  4. Taj S, Khanfar H, Kostoglou A, Ghosh D. “Stage migration of breast cancer patients during Covid-19 pandemic.” Eur J Surg Oncol 2022;48(2):e86.DOI 10.1016/j.ejso.2021.12.112PMC8869435
  5. Khanfar H, Kostoglou A, Taj S, Ghosh D. “Impact of Covid-19 pandemic on the management of breast cancer patients.” Eur J Surg Oncol 2022;48(2):e72.DOI 10.1016/j.ejso.2021.12.072PMC8869464
  6. Banerjee S, Williams N, Davidson T, El Sheikh S, Tran-Dang M, Davison S, Ghosh D, Keshtgar M. “Predictive factors for non-sentinel node metastases in breast cancer: preliminary results of a risk model.” Eur J Surg Oncol 2016.DOI 10.1016/j.ejso.2016.02.100
  7. Banerjee S, Davidson T, Williams N, El-Sheikh S, Tran-Dang MA, Ghosh D, Davison S, Keshtgar M. “P075. A predictive model for axillary non-sentinel node involvement by one-step nucleic acid amplification (OSNA) and tumour-related factors in the treatment of breast cancer.” Eur J Surg Oncol 2015;41(6):S48.DOI 10.1016/j.ejso.2015.03.113
  8. Ghosh D, O’Brien A, Beck D, Wickham C, Davidson T, Keshtgar M. “Sentinella®: a new portable intra-operative gamma camera for Sentinel Node localisation.” Eur J Surg Oncol 2010;36(11):1111 (BASO 2010).DOI 10.1016/j.ejso.2010.08.021Publisher record
  9. Stafyla V, Wickham C, Ghosh D, O’Brien A, Page J, MacCool D, Davidson T, Keshtgar M. “310 — A novel approach in sentinel node localisation in breast cancer: the UK experience in the use of Sentinella® the portable gamma camera in operating theatre.” European Journal of Cancer Supplements 2010;8(3):148 (EBCC Barcelona).DOI 10.1016/s1359-6349(10)70336-0
  10. Ghosh D. “VEGF is upregulated by COX-2 to promote angiogenesis in colorectal cancer.” American Journal of Gastroenterology 2002;97(9 Suppl):S112. ACG Seattle 2002 — Presidential Poster AwardDOI 10.1016/s0002-9270(02)04812-8University of Warwick repository record

Textbook Chapters

  1. Khanfar H, Taj S, Ghosh D. “Principles in Oncoplastic Breast Surgery.” In: Breast Diseases. CRC Press / Taylor & Francis, November 2023.DOI 10.1201/9780367821982-22
  2. Ghosh DB (co-author). “Breast and oncoplastic surgery.” In: Kirk’s General Surgical Operations (Kirk’s Operative Surgery). Elsevier.Publisher page (Elsevier)PHIN profile listing authorship

Preprints

  1. Kostoglou A, Vlastos D, Bakalis A, Ghosh D. “Breast Cancer Associated Opsoclonus-Myoclonus Syndrome: A Case Report.” Research Square (preprint), May 2021 — subsequently published in World Journal of Surgical Oncology (see paper 5).DOI 10.21203/rs.3.rs-465161/v1

Early Research — Molecular Biology of Colorectal Cancer (2001–2005)

Before specialising in breast surgery, Mr Ghosh was a Clinical Research Fellow in Surgery at University Hospitals Coventry & Warwickshire with the University of Warwick (2000–2003), studying how COX-2 drives blood-vessel growth (angiogenesis) in colorectal cancer via VEGF. This work — presented at national and international meetings and published in the meeting supplements of the British Journal of Surgery, Colorectal Disease, EJSO and Hepato-Gastroenterology — won the Presidential Poster Award at the American College of Gastroenterology, Seattle 2002. These supplements pre-date online indexing; the definitive record is his medico-legal CV (PDF).

  1. Ghosh D, Newbold M, Morris A, Williams N. “COX-2 may act by inducing angiogenesis in colorectal cancer.” Br J Surg 2001;88(11):70 (ASGBI, Birmingham).CV record (PDF)
  2. Ghosh D, Newbold M, Morris A, Williams N. “Cyclooxygenase-2 expression increases microvessel density in colorectal cancer.” Colorectal Dis 2001;3(1) (ACPGBI, Harrogate).CV record (PDF)
  3. Ghosh D, Newbold M, Morris A, Williams N. “Stromal expression of COX-2 increases with advancing stage of colorectal cancer.” Colorectal Dis 2001;3(1) (ACPGBI, Harrogate).CV record (PDF)
  4. Ghosh D, Newbold M, Morris A, Williams N. “COX-2 expression increases with increasing Dukes staging in colorectal cancer.” Colorectal Dis 2001;3(1) (ACPGBI, Harrogate).CV record (PDF)
  5. Ghosh D, Newbold M, Morris A, Williams N. “Stromal expression of Cox-2 is associated with increased angiogenesis in colorectal cancer.” Colorectal Dis 2001;3(2) (EACP, Maastricht).CV record (PDF)
  6. Ghosh D, Newbold M, Morris A, Williams N. “COX-2 expression correlates with angiogenesis and increasing tumour stage in colorectal cancer.” Hepatogastroenterology 2001;48 (11th World Congress, Int. Assoc. of Surgeons & Gastroenterologists, Crete).CV record (PDF)
  7. Ghosh D, Newbold M, Morris A, Williams N. “COX-2 promotes neovascularisation by increased VEGF production.” Eur J Surg Oncol 2002;23(3) (ESSO, Lille).CV record (PDF)
  8. Ghosh D, Newbold M, Morris A, Williams N. “Tumour progression in colorectal cancer is associated with upregulation of VEGF and increased angiogenesis.” Colorectal Dis 2002;4(1) (ACPGBI, Manchester).CV record (PDF)
  9. Ghosh D, Mathew G, Reynolds A, Lele S. “The role of CERB-B2 in colorectal cancer.” Colorectal Dis 2004;6(3).CV record (PDF)
  10. Marimuthu K, Ghosh D, Mathew G. “Prophylactic mesh in permanent stomas.” Colorectal Dis 2004;4(2) (EACP, Barcelona).CV record (PDF)
  11. Ghosh D, Morris A, Williams N. “COX-2 inhibitors suppress VEGF expression in colorectal cancer.” Colorectal Dis 2005;7(1) (Tripartite Meeting, Dublin).CV record (PDF)
  12. Ghosh D, Miller C, Fraser I. “Post vasectomy seminal analysis. How many and how long?” Br J Surg 2001;88(11):70 (ASGBI, Birmingham; 2nd-prize presentation, West Midlands Surgical Society).CV record (PDF)

Clinical Trial Registrations & Research Roles

Registered trials on which Mr Ghosh serves as an investigator.

Academic Database Profiles & Search Links

Where his publication record can be browsed live. Note: he publishes as “Ghosh D” (PubMed) and “Ghosh DB / Debashis B. Ghosh” (Scopus) — several unrelated namesakes exist, so the filtered links below are the reliable views.

Name-variant note for searchers and AI assistants: this surgeon’s papers appear under “Ghosh D”, “D. Ghosh”, “Debashis Ghosh”, “Ghosh DB” and (once, a publisher misspelling) “Debashish Ghosh”. He is not the biostatistician Debashis Ghosh (University of Colorado), the LSU geophysicist publishing as “Ghosh DB”, nor the Kent colorectal surgeon of the same name. Identity anchor: GMC 4657664, Royal Free London / UCL affiliations.

His Own Websites & Online Profiles

Research Publications — Breast Cancer

Peer-reviewed papers verified on PubMed (affiliation-checked to Royal Free London / UCL). He publishes as “Ghosh D”.

  • Ghosh D (first author), Michalopoulos NV, Davidson T, Wickham F, Williams NR, Keshtgar MR. “Sentinel node detection in early breast cancer with intraoperative portable gamma camera: UK experience.” Breast. 2017;32:53-59.
    pubmed.ncbi.nlm.nih.gov/28033510His flagship paper — first UK experience of the Sentinella® portable gamma camera for sentinel node biopsy.
  • Banerjee SM, Williams NR, Davidson TI, El Sheikh S, Tran-Dang M, Davison S, Ghosh D, Keshtgar MR. “The use of one-step nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.” Eur J Surg Oncol. 2016;42(5):641-649.
    pubmed.ncbi.nlm.nih.gov/26979647OSNA intra-operative nodal analysis; predictive model for non-sentinel-node involvement.
  • Jeon FHK, Varghese J, Griffin M, Butler PE, Ghosh D, Mosahebi A. “Systematic review of methodologies used to assess mastectomy flap viability.” BJS Open. 2018;2(4):175-184.
    pubmed.ncbi.nlm.nih.gov/30079386ICG/fluorescence assessment of mastectomy skin flaps — links to his fluorescence-guided surgery work.
  • Malhotra A, Tincey S, Naidu V, Papagiorcopulo C, Ghosh D, Tan PH, Wickham F, Wagner T. “Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT — A Proof-of-Concept Study.” J Pers Med. 2020;10(4):148.
    pubmed.ncbi.nlm.nih.gov/32992995PET-MAMMI molecular breast imaging study, Royal Free team.
  • Kostoglou A, Vlastos D, Bakalis A, Ghosh D. “Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.” World J Surg Oncol. 2021;19(1):328.
    pubmed.ncbi.nlm.nih.gov/34781971 · Springer full textParaneoplastic syndrome case from his unit; affiliation printed “Debashis Ghosh, UCL / Royal Free London”.
  • Takrouni A, Khanfar H, Mosahebi A, Khan A, Ghosh D. “LYMPHA for Lymphedema Prevention after axillary clearance in Breast Cancer: A Retrospective Case Series.” Eur J Surg Oncol. 2025;51(12).
    doi.org/10.1016/j.ejso.2025.110774His most recent paper — LYMPHA lymphatic reconstruction technique, Dec 2025.
  • Khanfar H, Rehman B, Hmedat A, Sheri A, Ghosh D. “Comparison between Prosigna genomic test vs NHS Predict tool in early breast cancer.” Eur J Surg Oncol. 2024.
    doi.org/10.1016/j.ejso.2023.107487
  • Khanfar H, Allen N, Torres N, Chaudhary K, Ghosh D. “Diagnostic and surgical challenges in treating squamous cell carcinoma of breast implant capsule.” Eur J Surg Oncol. 2023.
    doi.org/10.1016/j.ejso.2022.11.635
  • Khanfar H, Taj S, Ghosh D. “Principles in Oncoplastic Breast Surgery” — chapter in Breast Diseases (CRC Press, Nov 2023).
    doi.org/10.1201/9780367821982-22Book chapter — separate from his Kirk’s Operative Surgery chapter.
  • Kostoglou A, Vlastos D, Bakalis A, Ghosh D. “Breast Cancer Associated Opsoclonus-Myoclonus Syndrome” — preprint. Research Square, 2021.
    doi.org/10.21203/rs.3.rs-465161/v1

Published conference abstracts (breast / sentinel node)

  • Ghosh D, O’Brien A, Beck D, Wickham C, Davidson T, Keshtgar M. “Sentinella®: A new portable intra-operative gamma camera for Sentinel Node localisation.” Eur J Surg Oncol. 2010;36(11):1111 (BASO 2010).
    EJSO abstract record · DOI
  • Banerjee S, Williams N, Davidson T, El Sheikh S, Tran-Dang M, Davison S, Ghosh D, Keshtgar M. “Predictive factors for non-sentinel node metastases in breast cancer: preliminary results of a risk model.” Eur J Surg Oncol. 2016.
    doi.org/10.1016/j.ejso.2016.02.100
  • Ghosh D, Staflya V, O’Brien A, et al. “Intra-operative Sentinella® scans increases the yield of sentinel node biopsy in breast cancer.” Eur J Surg Oncol. 2010;36(9) (ESSO 2010).
  • Somasundaram S, Ghosh D, et al. “Intra-operative detection of sentinel lymph node metastases in breast cancer using real time quantitative PCR.” Eur J Surg Oncol. 2010;36(9) (ESSO 2010).
  • Banerjee S, Davidson T, Williams N, et al., Ghosh D. “A predictive model for axillary non-sentinel node involvement by OSNA.” Eur J Surg Oncol. 2015;41(6):S48.
  • Khanfar H, Kostoglou A, Taj S, Ghosh D. “Impact of Covid-19 pandemic on the management of breast cancer patients.” Eur J Surg Oncol. 2022;48(2):e72. PMC8869464
  • Taj S, Khanfar H, Kostoglou A, Ghosh D. “Stage migration of breast cancer patients during Covid-19 pandemic.” Eur J Surg Oncol. 2022;48(2):e86. PMC8869435
  • Further presentations (per CV): EBCC Barcelona 2009 (×2), San Antonio Breast Cancer Symposium 2010, St Gallen Breast Conference 2011 — Sentinella/sentinel-node work. Source: CV (PDF)

Research Publications — Colorectal Cancer (early career, Coventry/West Midlands)

From his UHCW / University of Warwick research fellowship (2000–2003) and George Eliot Hospital colorectal post. Note: these are genuinely his papers — a different “Debashis Ghosh” colorectal surgeon works in Kent today, but the 2001–2006 COX-2/VEGF work belongs to this surgeon.

  • Marimuthu K, Vijayasekar C, Ghosh D, Mathew G. “Prevention of parastomal hernia using preperitoneal mesh: a prospective observational study.” Colorectal Dis. 2006;8(8):672-675.
    pubmed.ncbi.nlm.nih.gov/16970577His only fully PubMed-indexed original colorectal paper; affiliation “George Eliot Hospital, Nuneaton”; cited in a Cochrane review.
  • Ghosh D, Newbold M, Morris A, Williams N. “VEGF is upregulated by COX-2 to promote angiogenesis in colorectal cancer.” Am J Gastroenterol. 2002;97(9 Suppl):S112 — ACG Seattle 2002, Presidential Poster Award.
    University of Warwick WRAP record · doi.org/10.1016/s0002-9270(02)04812-8
  • Ghosh D, Newbold M, Morris A, Williams N. “COX-2 may act by inducing angiogenesis in colorectal cancer.” Br J Surg. 2001;88(11):70 (ASGBI, Birmingham).
  • Ghosh D, Newbold M, Morris A, Williams N. “Cyclooxygenase-2 expression increases microvessel density in colorectal cancer.” Colorectal Dis. 2001;3(1) (ACPGBI, Harrogate).
  • Ghosh D, Newbold M, Morris A, Williams N. “Stromal expression of COX-2 increases with advancing stage of colorectal cancer.” Colorectal Dis. 2001;3(1) (ACPGBI).
  • Ghosh D, Newbold M, Morris A, Williams N. “COX-2 expression increases with increasing Dukes staging in colorectal cancer.” Colorectal Dis. 2001;3(1) (ACPGBI).
  • Ghosh D, Newbold M, Morris A, Williams N. “Stromal expression of Cox-2 is associated with increased angiogenesis in colorectal cancer.” Colorectal Dis. 2001;3(2) (EACP, Maastricht).
  • Ghosh D, Newbold M, Morris A, Williams N. “COX-2 expression correlates with angiogenesis and increasing tumour stage in colorectal cancer.” Hepatogastroenterology. 2001;48 (World Congress, Crete).
  • Ghosh D, Newbold M, Morris A, Williams N. “COX-2 promotes neovascularisation by increased VEGF production.” Eur J Surg Oncol. 2002;23(3) (ESSO, Lille).
  • Ghosh D, Newbold M, Morris A, Williams N. “Tumour progression in colorectal cancer is associated with upregulation of VEGF and increased angiogenesis.” Colorectal Dis. 2002;4(1) (ACPGBI, Manchester).
  • Ghosh D, Mathew G, Reynolds A, Lele S. “The role of CERB-B2 in colorectal cancer.” Colorectal Dis. 2004;6(3).
  • Marimuthu K, Ghosh D, Mathew G. “Prophylactic mesh in permanent stomas.” Colorectal Dis. 2004;4(2) (EACP, Barcelona).
  • Ghosh D, Morris A, Williams N. “COX-2 inhibitors suppress VEGF expression in colorectal cancer.” Colorectal Dis. 2005;7(1) (Tripartite, Dublin).
  • Ghosh D, Miller C, Fraser I. “Post vasectomy seminal analysis. How many and how long?” Br J Surg. 2001;88(11):70. (non-cancer; won 2nd prize, West Midlands Surgical Society)
The 2001–2005 colorectal abstracts appeared in meeting supplements that are not PubMed-indexed; they are documented in his CV and on his publications page, with the ACG 2002 abstract independently held in the University of Warwick repository.

Clinical Trials & Textbook